198 related articles for article (PubMed ID: 22300665)
1. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.
Abdel-Aziz A; Amin MM
Diagn Pathol; 2012 Feb; 7():14. PubMed ID: 22300665
[TBL] [Abstract][Full Text] [Related]
2. Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma.
Ahlem B; Wided A; Amani L; Nadia Z; Amira A; Faten F
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Nov; 132(5):275-9. PubMed ID: 26386615
[TBL] [Abstract][Full Text] [Related]
3. EGFR is not amplified in ameloblastoma.
Costa V; Fregnani ER; Fonseca FP; Abreu Alves F; Pinto CAL; Kaminagakura E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):454-458. PubMed ID: 29602688
[TBL] [Abstract][Full Text] [Related]
4. The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy.
Yang Y; Xuan J; Yang Z; Han A; Xing L; Yue J; Hu M; Yu J
Med Oncol; 2012 Sep; 29(3):1448-55. PubMed ID: 21786012
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of BRAF, EGFR and CD10 in ameloblastoma.
Tan CC; Siar CH; Shanmuhasuntharam P
Malays J Pathol; 2022 Apr; 44(1):19-28. PubMed ID: 35484883
[TBL] [Abstract][Full Text] [Related]
7. CD10 expression in stromal cells of ameloblastoma variants.
Iezzi G; Piattelli A; Rubini C; Artese L; Goteri G; Fioroni M; Carinci F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):206-9. PubMed ID: 17942343
[TBL] [Abstract][Full Text] [Related]
8. Cystic ameloblastoma--behavior and treatment of 21 cases.
Rosenstein T; Pogrel MA; Smith RA; Regezi JA
J Oral Maxillofac Surg; 2001 Nov; 59(11):1311-6; discussion 1316-8. PubMed ID: 11688034
[TBL] [Abstract][Full Text] [Related]
9. CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.
Masloub SM; Abdel-Azim AM; Elhamid ES
Diagn Pathol; 2011 May; 6():44. PubMed ID: 21609487
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study.
da Silva LP; Serpa MS; Santana T; do Nascimento GJ; de Souza Andrade ES; Sobral AP
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1089-1095. PubMed ID: 27747382
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.
Silva FP; Dias A; Coelho CA; Guerra EN; Marques AE; Decurcio DA; Mantesso A; Cury SE; Silva BS
Braz Oral Res; 2016 Oct; 30(1):e109. PubMed ID: 27737362
[TBL] [Abstract][Full Text] [Related]
12. Recurrent ameloblastoma of the mandible with unusual granular cell component.
Argyris PP; McBeain MJ; Rake A; Pambuccian SE; Gopalakrishnan R; Koutlas IG
Int J Surg Pathol; 2015 Jun; 23(4):298-304. PubMed ID: 25673632
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia secondary to a pseudoparathormone-secreting ameloblastoma.
McGuirt WF; Scruggs MS; Koufman JA
Arch Otolaryngol; 1981 Aug; 107(8):487-90. PubMed ID: 6264904
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
Han B; Li L; Wang H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
[TBL] [Abstract][Full Text] [Related]
16. P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas.
Florescu A; Simionescu C; Ciurea R; Pitru A
Rom J Morphol Embryol; 2012; 53(1):105-9. PubMed ID: 22395508
[TBL] [Abstract][Full Text] [Related]
17. Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients.
Li TJ; Wu YT; Yu SF; Yu GY
Am J Surg Pathol; 2000 Oct; 24(10):1385-92. PubMed ID: 11023100
[TBL] [Abstract][Full Text] [Related]
18. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
19. BRAF-V600E expression correlates with ameloblastoma aggressiveness.
Fregnani ER; Perez DE; Paes de Almeida O; Fonseca FP; Soares FA; Castro-Junior G; Alves FA
Histopathology; 2017 Feb; 70(3):473-484. PubMed ID: 27681305
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and proliferative evaluation of ameloblastoma based on radiographic boundary.
Li Y; Han B; Li LJ
Int J Oral Sci; 2012 Mar; 4(1):30-3. PubMed ID: 22361946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
